Partner Randy D. Gordon, chair of the Firm’s antitrust and trade regulation practice, authored an article for Law360 regarding the merger between Anheuser-Busch InBev and its rival SAB Miller.
“The antitrust and related regulatory issues with this merger are legion,” said Mr. Gordon. “The first question many antitrust lawyers ask themselves when setting down to analyze the ramifications of any proposed transaction is, ‘Who’s going to complain?’ Here, the answer is, ‘Lots of people.’”
Subscribers can access the full article here.
Related Insights
July 30, 2025
Health Care Law Today
Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM): What You Need to Know About CMS’ Proposed Changes
On July 14, 2025, the Centers for Medicare and Medicaid Services (CMS) proposed key changes to remote patient monitoring (RPM) and remote…
July 30, 2025
Foley Viewpoints
US Considers Charging Fees Based on Patent Value
The Trump administration is reportedly considering a proposal to charge patent holders a fee based on the value of their patents,…
July 30, 2025
Foley Viewpoints
U.S. FinCEN's Order Targeting CIBanco Will Upend Mexican Fiduciary Market
In late June 2025, the U.S. Treasury's FinCEN (Financial Crimes Enforcement Network), under new authorities granted pursuant to the…